Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_1
1
20%
Ph phase_3
2
40%
Ph phase_4
2
40%

Phase Distribution

1

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Terminated(1)

Detailed Status

Completed4
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (20.0%)
Phase 32 (40.0%)
Phase 42 (40.0%)

Trials by Status

terminated120%
completed480%

Recent Activity

0 active trials
Showing 5 of 5
terminatedphase_3

Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?

NCT04606563
completedphase_3

Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension

NCT01631227
completedphase_1

Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers

NCT01087749
completedphase_4

The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension

NCT00438945
completedphase_4

The Effect of Eprosartan on Hormones and Kidney Function in Healthy Humans.

NCT00409903

Clinical Trials (5)

Showing 5 of 5 trials
NCT04606563Phase 3

Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?

Terminated
NCT01631227Phase 3

Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension

Completed
NCT01087749Phase 1

Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers

Completed
NCT00438945Phase 4

The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension

Completed
NCT00409903Phase 4

The Effect of Eprosartan on Hormones and Kidney Function in Healthy Humans.

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5